Expiration date: 07/2026

Action:

Stimulates bone formation in bone tissue culture, stimulates the replication of the precursors of osteoblasts and collagen synthesis in culture of bone cells

Composition:

Strontium ranelate, auxiliary components

Indications:

Treatment of severe osteoporosis in women in postmenopausal period with high risk of fracture to reduce the risk of vertebral fractures and a femur, including hip fracture. The treatment of severe osteoporosis in men with increased risk of fractures with the purpose to reduce it.